Robert J. Brown, Charles Sholtz, Francis Crick, James Watson, George Church, Leroy Hood, Eugene Myers, Bernhard Palsson | GenomeWeb

Robert J. Brown has joined Atlanta-based Serologicals as vice president of corporate development. He will be responsibile for leading the corporate development activities in identifying, evaluating, and pursuing acquisition opportunities. Brown has over 22 years of experience in corporate development and licensing for major pharmaceutical companies, including 15 years with Bristol-Myers Squibb, where his experience included leading its corporate development function for the United States.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.